REGENEREX PHARMA, INC. Quarterly Interest Expense in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regenerex Pharma, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2012 to Q3 2024.
  • Regenerex Pharma, Inc. Interest Expense for the quarter ending September 30, 2024 was $266K, a 1244% increase year-over-year.
  • Regenerex Pharma, Inc. Interest Expense for the twelve months ending September 30, 2024 was $331K, a 353% increase year-over-year.
  • Regenerex Pharma, Inc. annual Interest Expense for 2023 was $80.6K, a 20.7% increase from 2022.
  • Regenerex Pharma, Inc. annual Interest Expense for 2022 was $66.8K, a 13.1% increase from 2021.
  • Regenerex Pharma, Inc. annual Interest Expense for 2021 was $59.1K, a 37.7% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $331K $266K +$246K +1244% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $84.5K $22.3K +$3.83K +20.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $80.6K $22.1K +$4.69K +26.9% Jan 1, 2024 Mar 31, 2024 10-K 2024-06-24
Q4 2023 $75.9K $20.2K +$2.98K +17.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-05
Q3 2023 $73K $19.8K +$3.19K +19.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $69.8K $18.5K +$2.99K +19.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $66.8K $17.4K +$2.49K +16.7% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-24
Q4 2022 $64.3K $17.2K +$2.69K +18.5% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-05
Q3 2022 $61.6K $16.6K -$233 -1.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $61.8K $15.5K +$2.78K +21.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $59.1K $14.9K +$3.36K +29.1% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-09
Q4 2021 $55.7K $14.5K +$3.35K +29.9% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-24
Q3 2021 $52.4K $16.8K +$6.03K +55.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $46.3K $12.7K +$3.42K +36.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $42.9K $11.6K +$829 +7.72% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-28
Q4 2020 $42.1K $11.2K +$3.18K +39.5% Oct 1, 2020 Dec 31, 2020 10-Q/A 2022-02-03
Q3 2020 $38.9K $10.8K +$4.05K +59.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 $34.9K $9.32K +$6.2K +198% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $28.7K $10.7K Jan 1, 2020 Mar 31, 2020 10-K 2021-06-23
Q4 2019 $8.03K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $6.76K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $3.13K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q4 2014 $3.56K $2.64K -$681 -20.5% Sep 1, 2014 Nov 30, 2014 10-K 2015-03-03
Q3 2014 $4.24K $1.09K -$10 -0.91% Jun 1, 2014 Aug 31, 2014 10-Q 2014-10-20
Q2 2014 $4.25K $713 -$172 -19.4% Mar 1, 2014 May 31, 2014 10-Q/A 2014-07-23
Q1 2014 $4.42K -$886 +$41.00 +4.42% Dec 1, 2013 Feb 28, 2014 10-Q 2014-04-11
Q4 2013 $4.38K $3.32K Sep 1, 2013 Nov 30, 2013 10-K 2015-03-03
Q3 2013 $1.1K +$2.04K Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-20
Q2 2013 $885 -$7.87K -89.9% Mar 1, 2013 May 31, 2013 10-Q/A 2014-07-23
Q1 2013 -$927 Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-11
Q3 2012 -$946 Jun 1, 2012 Aug 31, 2012 10-Q 2012-10-15
Q2 2012 $8.76K Mar 1, 2012 May 31, 2012 10-Q 2013-07-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.